Stay updated on Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page's Revision label changed from v3.5.3 to v3.5.4 to reflect a new site release; no other study content or details appear to be modified.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe page footer’s software/application revision indicator was updated from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the history. This is a page-version update rather than a change to trial content or results.SummaryDifference0.1%

- Check86 days agoChange DetectedA new version entry v3.4.3 was added and the previous version v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check108 days agoChange DetectedAdded revision label v3.4.2 and removed v3.4.1 from the history log.SummaryDifference0.1%

- Check115 days agoChange DetectedSanofi is now listed as sponsor/collaborators; Provention Bio is removed. The page history now includes a Study Status section.SummaryDifference0.8%

Stay in the know with updates to Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.